Abstract

The pathophysiology of severe COVID-19 involves a hyperactive immune response often referred to as cytokine storm. This pathway may lead to different clinical phenotypes including acute respiratory distress syndrome, sepsis, cardiomyopathy, and/or multiple organ failure. Therapeutic plasma exchange (TPE) has been proposed as adjunct treatment for sepsis and cytokine storm with case reports and small trials showing clinical success. We present a case of Takotsubo cardiomyopathy with refractory cardiogenic shock that reversed following TPE. Our patient subsequently developed sepsis and again responded clinically to TPE. This case offers an exciting anecdotal outcome while generating hypotheses for further clinical research.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call